Publication:
Unintended HIV-1 Infection During Analytical Therapy Interruption

dc.contributor.authorUgarte, Ainoa
dc.contributor.authorRomero, Yolanda
dc.contributor.authorTricas, Amparo
dc.contributor.authorCasado, Concepcion
dc.contributor.authorLopez-Galindez, Luis Cecilio
dc.contributor.authorGarcía, Felipe
dc.contributor.authorLeal, Lorna
dc.contributor.funderMinisterio de Economía (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderRETICS-Sida (RIS-ISCIII) (España)
dc.contributor.funderGovernment of Catalonia (España)
dc.date.accessioned2025-01-15T10:55:07Z
dc.date.available2025-01-15T10:55:07Z
dc.date.issued2020-04-27
dc.description.peerreviewed
dc.description.sponsorshipThis work was partially supported by the following grants: the Spanish Ministry of Economy (MINECO) (grants: SAF2015-66193-R, RTI2018-096309-B-I00), the Fondo de Investigación Sanitaria (FIS) PI15/00480, the Fondo Europeo para el Desarrollo Regional (FEDER), the SPANISH AIDS Research Network RD16/0025/0002–ISCIII–FEDER (RIS), and the CERCA Programme/Generalitat de Catalunya SGR 615 and SGR 653. F.G. has received support from José María Segovia de Arana contracts. Work in C. L.-G.’s laboratory was supported by grants SAF (2010–17226) and (2016-77894-R) from MINECO (Spain) and FIS (PI 13/02269, ISCIII) and in part by the RIS-RETIC grants RD06/006/0036 and RD12/0017/0028 funded by the ISC III-FEDER.
dc.format.number10
dc.format.page1740-1742
dc.format.volume221
dc.identifier.citationUgarte A, Romero Y, Tricas A, Casado C, Lopez-Galindez C, Garcia F, Leal L. Unintended HIV-1 Infection During Analytical Therapy Interruption. J Infect Dis. 2020 Apr 27;221(10):1740-1742.
dc.identifier.doi10.1093/infdis/jiz611
dc.identifier.e-issn1537-6613
dc.identifier.issn0022-1899
dc.identifier.journalThe Journal of infectious diseases
dc.identifier.pubmedID31742347
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26023
dc.language.isoeng
dc.publisherOxford University Press
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//SAF2015-66193-R/ES/UTILIZACION DE MEDICINA DE SISTEMAS PARA LA PREDICCION DE LA INMUNOGENICIDAD Y EFICACIA DE VACUNAS TERAPEUTICAS FRENTE A VIH/
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-096309-B-I00/ES/DESARROLLO PRECLINICO DE UNA INNOVADORA VACUNA ARNM CONTRA EL VIH/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//PI15%2F00480/ES/DESARROLLO DE UNA VACUNA TERAPÉUTICA FRENTE AL VIH BASADA EN UNA NUEVA FORMULACIÓN DE mRNA CON NANOPARTÍCULAS/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//RD16%2F0025%2F0002/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN SIDA (RIS)/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI13/02269
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD06/006/0036
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0017/0028
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2010–17226-R
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2016-77894-R
dc.relation.publisherversionhttps://doi.org/10.1093/infdis/jiz611
dc.repisalud.centroISCIII::Centro Nacional de Microbiología (CNM)
dc.repisalud.institucionISCIII
dc.repisalud.instituteIIS::IDIBAPS - Instituto de Investigaciones Biomédicas August Pi i Sunyer (Cataluña)
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshAIDS Vaccines
dc.subject.meshAdult
dc.subject.meshAnti-HIV Agents
dc.subject.meshAnti-HIV Agents
dc.subject.meshDrug Contamination
dc.subject.meshHIV Infections
dc.subject.meshHIV Infections
dc.subject.meshHIV-1
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshPhylogeny
dc.subject.meshSexual Partners
dc.titleUnintended HIV-1 Infection During Analytical Therapy Interruption
dc.typeletter to the editor
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication7e48a263-54c3-4de0-81e7-f7446c918f2d
relation.isAuthorOfPublicationf57c2687-907b-44ea-a780-7920ff8b9b41
relation.isAuthorOfPublication7e48a263-54c3-4de0-81e7-f7446c918f2d
relation.isAuthorOfPublication.latestForDiscovery7e48a263-54c3-4de0-81e7-f7446c918f2d
relation.isFunderOfPublicationca7182dc-aaab-45ec-a09d-755563fe05f2
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublicationcf779d8b-1517-4249-81b7-65344ce5172d
relation.isFunderOfPublicationc6fbffec-abb4-4f0e-81e0-3b254d5dd85d
relation.isFunderOfPublication.latestForDiscoveryca7182dc-aaab-45ec-a09d-755563fe05f2
relation.isPublisherOfPublication465a0b1e-d9df-4342-b738-86ffcafc4bcf
relation.isPublisherOfPublication.latestForDiscovery465a0b1e-d9df-4342-b738-86ffcafc4bcf

Files